Need help finding what you are looking for?
Contact Us
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1363809
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1363809
Global Imatinib Drug Market Size study & Forecast, by Drug Formulation by Application Type and Regional Analysis, 2023-2030
PUBLISHED:
PAGES:
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Imatinib drug is used to treat certain types of cancer. It belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs). Imatinib specifically targets and inhibits the activity of abnormal proteins called tyrosine kinases, which are produced by specific cancer cells. Imatinib is primarily used for the treatment of chronic myeloid leukemia (CML), a type of blood cancer characterized by the overproduction of abnormal white blood cells. It can also be prescribed for the treatment of gastrointestinal stromal tumors (GISTs), a type of tumor that occurs in the gastrointestinal tract. The Imatinib Drug market is expanding because of factors such as Increasing incidence of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs) and increase in demand for target drug therapy.
Imatinib has demonstrated remarkable success in the treatment of CML, leading to high response rates and improved long-term outcomes. Thus, Rising prevelance of chronic myeloid leukemia is driving the market growth. According to National Library of Medicine, The prevalence of chronic myeloid leukemia (CML) across the globe is 112,000 in year 2020, and it is projected to increase to 144,000 by year 2030, and 167,000 cased by year 2040 and 181,000 cases by year 2050. The rising prevelance of chronic myeloid leukemia across the globe is driving the market growth. In addition, rise in healthcare expenditure and increasing R&D activities related to imatinib drug development is creating a lucrative opportunity in the market. However, high cost of imatinib drug and availability of substitutes stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Imatinib Drug Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in year 2022 owing to presence of key market players, rising development of drug, rising prevelance of cancer disease in the region. Whereas Asia Pacific is witnessing a significant growth owing to factors such as rising prevelance of cancer in the region, rising investment in drug discovery activities, rising government initiatives for promoting drug development activities.
Major market player included in this report are:
- Sun Pharmaceutical Industries Ltd.
- Novartis AG
- Dr. Reddy's Laboratories Ltd
- Teva Pharmaceutical Industries Ltd.
- Mylan N.V.
- Cipla Inc
- Apotex Inc
- Sanofi S.A
- Glenmark Pharmaceuticals Ltd.
- Dongbao Pharmaceutical Co. Ltd.
Recent Developments in the Market:
- In October 2021, Tenax Therapeutics, Inc. Announced that the FDA has reviewed and cleared its Investigational New Drug (IND) application for a novel formulation of imatinib.
Global Imatinib Drug Market Report Scope:
- Historical Data: 2020 - 2021
- Base Year for Estimation: 2022
- Forecast period: 2023-2030
- Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered: Drug Formulation, Application Type, Region
- Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
- Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Drug Formulation offerings of key players. The detailed segments and sub-segment of the market are explained below.
By Drug Formulation:
- Capsules
- Tablets
By Application Type:
- Philadelphia Positive Chronic Myeloid Leukemia
- Hyper-Eosinophilic Syndrome (HES)
- Myelodysplastic Syndrome (MDS)
- Myeloproliferative Diseases (MPD)
- Gastrointestinal Stromal Tumors (GIST)
- Others
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1. Imatinib Drug Market, by Region, 2020-2030 (USD Billion)
- 1.2.2. Imatinib Drug Market, by Drug Formulation, 2020-2030 (USD Billion)
- 1.2.3. Imatinib Drug Market, by Application Type, 2020-2030 (USD Billion)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Imatinib Drug Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Imatinib Drug Market Dynamics
- 3.1. Imatinib Drug Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
- 3.1.1.1. Increasing incidence of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs)
- 3.1.1.2. Increase in demand for target drug therapy.
- 3.1.2. Market Challenges
- 3.1.2.1. High Cost of Imatinib Drug
- 3.1.2.2. Availability of substitutes
- 3.1.3. Market Opportunities
- 3.1.3.1. Rise in healthcare expenditure
- 3.1.3.2. Increasing R&D activities related to imatinib.
- 3.1.1. Market Drivers
Chapter 4. Global Imatinib Drug Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Porter's 5 Force Impact Analysis
- 4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
- 4.4. Top investment opportunity
- 4.5. Top winning strategies
- 4.6. COVID-19 Impact Analysis
- 4.7. Disruptive Trends
- 4.8. Industry Expert Perspective
- 4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Imatinib Drug Market, by Drug Formulation
- 5.1. Market Snapshot
- 5.2. Global Imatinib Drug Market by Drug Formulation, Performance - Potential Analysis
- 5.3. Global Imatinib Drug Market Estimates & Forecasts by Drug Formulation 2020-2030 (USD Billion)
- 5.4. Imatinib Drug Market, Sub Segment Analysis
- 5.4.1. Capsules
- 5.4.2. Tablets
Chapter 6. Global Imatinib Drug Market, by Application Type
- 6.1. Market Snapshot
- 6.2. Global Imatinib Drug Market by Application Type, Performance - Potential Analysis
- 6.3. Global Imatinib Drug Market Estimates & Forecasts by Application Type 2020-2030 (USD Billion)
- 6.4. Imatinib Drug Market, Sub Segment Analysis
- 6.4.1. Philadelphia Positive Chronic Myeloid Leukemia
- 6.4.2. Hyper-Eosinophilic Syndrome (HES)
- 6.4.3. Myelodysplastic Syndrome (MDS)
- 6.4.4. Myeloproliferative Diseases (MPD)
- 6.4.5. Gastrointestinal Stromal Tumors (GIST)
- 6.4.6. Others
Chapter 7. Global Imatinib Drug Market, Regional Analysis
- 7.1. Top Leading Countries
- 7.2. Top Emerging Countries
- 7.3. Imatinib Drug Market, Regional Market Snapshot
- 7.4. North America Imatinib Drug Market
- 7.4.1. U.S. Imatinib Drug Market
- 7.4.1.1. Drug Formulation breakdown estimates & forecasts, 2020-2030
- 7.4.1.2. Application Type breakdown estimates & forecasts, 2020-2030
- 7.4.2. Canada Imatinib Drug Market
- 7.4.1. U.S. Imatinib Drug Market
- 7.5. Europe Imatinib Drug Market Snapshot
- 7.5.1. U.K. Imatinib Drug Market
- 7.5.2. Germany Imatinib Drug Market
- 7.5.3. France Imatinib Drug Market
- 7.5.4. Spain Imatinib Drug Market
- 7.5.5. Italy Imatinib Drug Market
- 7.5.6. Rest of Europe Imatinib Drug Market
- 7.6. Asia-Pacific Imatinib Drug Market Snapshot
- 7.6.1. China Imatinib Drug Market
- 7.6.2. India Imatinib Drug Market
- 7.6.3. Japan Imatinib Drug Market
- 7.6.4. Australia Imatinib Drug Market
- 7.6.5. South Korea Imatinib Drug Market
- 7.6.6. Rest of Asia Pacific Imatinib Drug Market
- 7.7. Latin America Imatinib Drug Market Snapshot
- 7.7.1. Brazil Imatinib Drug Market
- 7.7.2. Mexico Imatinib Drug Market
- 7.8. Middle East & Africa Imatinib Drug Market
- 7.8.1. Saudi Arabia Imatinib Drug Market
- 7.8.2. South Africa Imatinib Drug Market
- 7.8.3. Rest of Middle East & Africa Imatinib Drug Market
Chapter 8. Competitive Intelligence
- 8.1. Key Company SWOT Analysis
- 8.1.1. Company 1
- 8.1.2. Company 2
- 8.1.3. Company 3
- 8.2. Top Market Strategies
- 8.3. Company Profiles
- 8.3.1. Sun Pharmaceutical Industries Ltd.
- 8.3.1.1. Key Information
- 8.3.1.2. Overview
- 8.3.1.3. Financial (Subject to Data Availability)
- 8.3.1.4. Product Summary
- 8.3.1.5. Recent Developments
- 8.3.2. Novartis AG
- 8.3.3. Dr. Reddy's Laboratories Ltd
- 8.3.4. Teva Pharmaceutical Industries Ltd.
- 8.3.5. Mylan N.V.
- 8.3.6. Cipla Inc
- 8.3.7. Apotex Inc
- 8.3.8. Sanofi S.A
- 8.3.9. Glenmark Pharmaceuticals Ltd.
- 8.3.10. Dongbao Pharmaceutical Co. Ltd.
- 8.3.1. Sun Pharmaceutical Industries Ltd.
Chapter 9. Research Process
- 9.1. Research Process
- 9.1.1. Data Mining
- 9.1.2. Analysis
- 9.1.3. Market Estimation
- 9.1.4. Validation
- 9.1.5. Publishing
- 9.2. Research Attributes
- 9.3. Research Assumption
LIST OF TABLES
- TABLE 1. Global Imatinib Drug Market, report scope
- TABLE 2. Global Imatinib Drug Market estimates & forecasts by Region 2020-2030 (USD Billion)
- TABLE 3. Global Imatinib Drug Market estimates & forecasts by Drug Formulation 2020-2030 (USD Billion)
- TABLE 4. Global Imatinib Drug Market estimates & forecasts by Application Type 2020-2030 (USD Billion)
- TABLE 5. Global Imatinib Drug Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 6. Global Imatinib Drug Market by region, estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 7. Global Imatinib Drug Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 8. Global Imatinib Drug Market by region, estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 9. Global Imatinib Drug Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 10. Global Imatinib Drug Market by region, estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 11. Global Imatinib Drug Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 12. Global Imatinib Drug Market by region, estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 13. Global Imatinib Drug Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 14. Global Imatinib Drug Market by region, estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 15. U.S. Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 16. U.S. Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 17. U.S. Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 18. Canada Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 19. Canada Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 20. Canada Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 21. UK Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 22. UK Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 23. UK Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 24. Germany Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 25. Germany Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 26. Germany Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 27. France Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 28. France Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 29. France Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 30. Italy Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 31. Italy Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 32. Italy Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 33. Spain Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 34. Spain Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 35. Spain Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 36. RoE Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 37. RoE Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 38. RoE Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 39. China Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 40. China Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 41. China Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 42. India Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 43. India Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 44. India Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 45. Japan Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 46. Japan Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 47. Japan Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 48. South Korea Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 49. South Korea Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 50. South Korea Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 51. Australia Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 52. Australia Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 53. Australia Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 54. RoAPAC Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 55. RoAPAC Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 56. RoAPAC Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 57. Brazil Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 58. Brazil Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 59. Brazil Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 60. Mexico Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 61. Mexico Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 62. Mexico Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 63. RoLA Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 64. RoLA Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 65. RoLA Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 66. Saudi Arabia Imatinib Drug Market estimates & forecasts, 2020-2030 (USD Billion)
- TABLE 67. South Africa Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 68. RoMEA Imatinib Drug Market estimates & forecasts by segment 2020-2030 (USD Billion)
- TABLE 69. List of secondary sources, used in the study of global Imatinib Drug Market
- TABLE 70. List of primary sources, used in the study of global Imatinib Drug Market
- TABLE 71. Years considered for the study
- TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
- FIG 1. Global Imatinib Drug Market, research methodology
- FIG 2. Global Imatinib Drug Market, Market estimation techniques
- FIG 3. Global Market size estimates & forecast methods
- FIG 4. Global Imatinib Drug Market, key trends 2022
- FIG 5. Global Imatinib Drug Market, growth prospects 2023-2030
- FIG 6. Global Imatinib Drug Market, porters 5 force model
- FIG 7. Global Imatinib Drug Market, pest analysis
- FIG 8. Global Imatinib Drug Market, value chain analysis
- FIG 9. Global Imatinib Drug Market by segment, 2020 & 2030 (USD Billion)
- FIG 10. Global Imatinib Drug Market by segment, 2020 & 2030 (USD Billion)
- FIG 11. Global Imatinib Drug Market by segment, 2020 & 2030 (USD Billion)
- FIG 12. Global Imatinib Drug Market by segment, 2020 & 2030 (USD Billion)
- FIG 13. Global Imatinib Drug Market by segment, 2020 & 2030 (USD Billion)
- FIG 14. Global Imatinib Drug Market, regional snapshot 2020 & 2030
- FIG 15. North America Imatinib Drug Market 2020 & 2030 (USD Billion)
- FIG 16. Europe Imatinib Drug Market 2020 & 2030 (USD Billion)
- FIG 17. Asia pacific Imatinib Drug Market 2020 & 2030 (USD Billion)
- FIG 18. Latin America Imatinib Drug Market 2020 & 2030 (USD Billion)
- FIG 19. Middle East & Africa Imatinib Drug Market 2020 & 2030 (USD Billion)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.